MedPath

Difference of Tear Ferning Between Women with and Without Menopausal.

Not Applicable
Recruiting
Conditions
Dry Eye Syndromes
Registration Number
NCT06848829
Lead Sponsor
Chung Shan Medical University
Brief Summary

Application of tear ferning test for clinical dry eye diagnosis and menopause

Detailed Description

Analyzing the difference in tear ferning structure between women pre and post-menopause with and without hormone replacement therapy (HRT). Tear and blood samples were collected for a menopause-related Enzyme-linked immunosorbent assay. Tear volume, tear osmolarity, intraocular pressure, and tear break-up time were also measured for comparison.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
90
Inclusion Criteria
  • Aged between 20 and 65 years
Exclusion Criteria
  • No evident ocular diseases such as cornea, cataracts, vitreous degeneration, glaucoma, and retinopathy.
  • Belong to vulnerable groups(pregnancy woman, prisoner, ethical minorities, economic or educationally disadvantaged subjects, disabled individuals such as those at terminal stage of tumorigenesis, blindness, terminal ill individuals)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Tear ferning30 minutes

crystal structure formed from tear drops on a slide be scored.

Ocular surface status3 minutes

To assess ocular surface health status with lissamine green stain, health or corneal abrasion.

Schirmer's test5 minutes

To assess tear secretion volume

Menopause related hormone Enzyme-linked immunosorbent assay (ELISA)3 hours

To assess FSH/LH/E2/Progesterone/Mc5AC/Lactoferrin concentration between pre- and post-manopause women.

Tear film breakup time20 seconds

To assess tear quality

Secondary Outcome Measures
NameTimeMethod
Ocular surface disease index20 minutes

A questionnaire to assess the health status on ocular surface

A final score is calculated which ranges from 0 to 100 with scores 0 to 12 representing normal, 13 to 22 representing mild dry eye disease, 23 to 32 representing moderate dry eye disease, and greater than 33 representing severe dry eye disease.

Intraocular pressure2 minutes

To determine the effects of intervention on intraocular pressure

Trial Locations

Locations (1)

Jen-Ai Hospital

🇨🇳

Taichung, Taiwan

© Copyright 2025. All Rights Reserved by MedPath